Advanced Biomed Inc. Common Stock (ADVB) — Financial Flexibility Index

Latest as of March 2026: 0.00x

Advanced Biomed Inc. Common Stock (ADVB) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $-6.86K (operating CF $-6.89K minus capex $34.59) represents 0% of total liabilities ($1.44 Million). Check ADVB capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

0.00x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-6.86K
Operating CF − Capex

Total Liabilities

$1.44 Million
USD

Capital Expenditures

$34.59
USD

Advanced Biomed Inc. Common Stock Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for Advanced Biomed Inc. Common Stock across 5 annual periods. For the full cash flow conversion analysis, see Advanced Biomed Inc. Common Stock (ADVB) cash conversion ratio.

Annual Financial Flexibility Index for Advanced Biomed Inc. Common Stock (2021–2025)

Year-by-year free cash flow to debt coverage for Advanced Biomed Inc. Common Stock. Explore Advanced Biomed Inc. Common Stock debt service capacity to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.06x $-180.48K $-181.46K $3.03 Million ▲ +91.9%
2024 -0.73x $-2.05 Million $-2.13 Million $2.80 Million ▲ +12.1%
2023 -0.84x $-2.75 Million $-2.96 Million $3.29 Million ▼ -571.5%
2022 0.18x $570.68K $-741.45K $3.22 Million ▲ +101.2%
2021 -14.89x $-448.53K $-473.98K $30.13K
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities